GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Merus NV (FRA:2GH) » Definitions » Accounts Payable

Merus NV (FRA:2GH) Accounts Payable : €3.98 Mil (As of Dec. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Merus NV Accounts Payable?

Merus NV's Accounts Payable for the quarter that ended in Dec. 2024 was €3.98 Mil.

Merus NV's quarterly Accounts Payable increased from Jun. 2024 (€4.08 Mil) to Sep. 2024 (€5.57 Mil) but then declined from Sep. 2024 (€5.57 Mil) to Dec. 2024 (€3.98 Mil).

Merus NV's annual Accounts Payable declined from Dec. 2022 (€9.28 Mil) to Dec. 2023 (€4.22 Mil) and declined from Dec. 2023 (€4.22 Mil) to Dec. 2024 (€3.98 Mil).


Merus NV Accounts Payable Historical Data

The historical data trend for Merus NV's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merus NV Accounts Payable Chart

Merus NV Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.57 11.72 9.28 4.22 3.98

Merus NV Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.22 6.89 4.08 5.57 3.98

Merus NV Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.


Merus NV Accounts Payable Related Terms

Thank you for viewing the detailed overview of Merus NV's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Merus NV Business Description

Traded in Other Exchanges
Address
Uppsalalaan 17, Utrecht, NLD, 3584 CT
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

Merus NV Headlines

No Headlines